Alzheimer's ad­comm mem­bers ques­tion FDA: How can you use amy­loid as the ba­sis for an ac­cel­er­at­ed ap­proval?

The FDA has not yet pro­vid­ed a per­sua­sive sci­en­tif­ic ba­sis for de­clar­ing be­ta-amy­loid as a rea­son­able sur­ro­gate for an ac­cel­er­at­ed ap­proval, sev­en mem­bers of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.